Assessment of the Neutralizing Antibody Response of BNT162b2 and mRNA-1273 SARS-CoV-2 Vaccines in Naïve and Previously Infected Individuals: A Comparative Study
Shurrab, F.M.; Al-Sadeq, D.W.; Abou-Saleh, H.; Al-Dewik, N.; Elsharafi, A.E.; Hamaydeh, F.M.; Halawa, B.Y.A.; Jamaleddin, T.M.; Hameed, H.M.A.; Nizamuddin, P.B.; Amanullah, F.H.; Daas, H.I.; Abu-Raddad, L.J.; Nasrallah, G.K. Assessment of the Neutralizing Antibody Response of BNT162b2 and mRNA-1273 SARS-CoV-2 Vaccines in Naïve and Previously Infected Individuals: A Comparative Study. Vaccines 2022, 10, 191. https://doi.org/10.3390/vaccines10020191
Shurrab FM, Al-Sadeq DW, Abou-Saleh H, Al-Dewik N, Elsharafi AE, Hamaydeh FM, Halawa BYA, Jamaleddin TM, Hameed HMA, Nizamuddin PB, Amanullah FH, Daas HI, Abu-Raddad LJ, Nasrallah GK. Assessment of the Neutralizing Antibody Response of BNT162b2 and mRNA-1273 SARS-CoV-2 Vaccines in Naïve and Previously Infected Individuals: A Comparative Study. Vaccines. 2022; 10(2):191. https://doi.org/10.3390/vaccines10020191
Chicago/Turabian StyleShurrab, Farah M., Duaa W. Al-Sadeq, Haissam Abou-Saleh, Nader Al-Dewik, Amira E. Elsharafi, Fatima M. Hamaydeh, Bushra Y.A. Halawa, Tala M. Jamaleddin, Huda M.A. Hameed, Parveen B. Nizamuddin, Fathima H. Amanullah, Hanin I. Daas, Laith J. Abu-Raddad, and Gheyath K. Nasrallah. 2022. "Assessment of the Neutralizing Antibody Response of BNT162b2 and mRNA-1273 SARS-CoV-2 Vaccines in Naïve and Previously Infected Individuals: A Comparative Study" Vaccines 10, no. 2: 191. https://doi.org/10.3390/vaccines10020191